Nano-medicine may be considered to be one of the most significant facets of the still nascent discipline of nanotechnology.

Nano Vivere (ISIN: CN0024013913), a late stage clinical company, pioneering nanomedicine whose technology is based on proprietary technologies and patents, today announced that it will discuss in a Nano-conference how nanorobotics (nano-medical devices) may have strong potential for enabling dramatic and beneficial paradigm shifts in virtually ever..

View more at https://www.1888pressrelease.com/nano-medical-robotics-non-invasive-surgery-and-cell-repair-pr-639965.html